Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 419-433 , June 2006

Reactive arthritis or post-infectious arthritis?

  • Timo Hannu, MD, PhD (Senior Research Fellow)

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Division of Rheumatology, Department of Medicine, Helsinki University Central Hospital, P.O. Box 263, FIN-00029 Huch, Finland. Tel.: +358 30 474 2575; Fax: +358 30 474 2149.

References 

  1. Hannu T, Mattila L, Rautelin H, et al. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology. 2002;41:312–318
  2. Hannu T, Mattila L, Siitonen A, et al. Reactive arthritis attributable to shigella infection: a clinical and epidemiological nationwide study. Annals of the Rheumatic Diseases. 2005;64:594–598
  3. Merilahti-Palo R, Lahesmaa R, Granfors K, et al. Risk of yersinia infection among butchers. Scandinavian Journal of Infectious Diseases. 1991;23:55–61
  4. Mäki-Ikola O, Granfors K. Salmonella-triggered reactive arthritis. Scandinavian Journal of Rheumatology. 1992;21:265–270
  5. Mäki-Ikola O, Granfors K. The bacteriology of reactive arthritis. Reviews in Medical Microbiology. 1993;4:144–150
  6. Granfors K, Viljanen M, Tiilikainen A, et al. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. The Journal of Infectious Diseases. 1980;141:424–429
  7. Mäki-Ikola O, Leirisalo-Repo M, Kantele A, et al. Salmonella-specific antibodies in reactive arthritis. The Journal of Infectious Diseases. 1991;164:1141–1148
  8. Sieper J, Rudwaleit M, Braun J, et al. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis and Rheumatism. 2002;46:319–327
  9. Sieper J, Braun J. Problems and advances in the diagnosis of reactive arthritis. The Journal of Rheumatology. 1999;26:1222–1224
  10. Isomäki O, Vuento R, Granfors K. Serological diagnosis of salmonella infections by enzyme immunoassay. Lancet. 1989;i:1411–1414
  11. Wang SP, Grayston JT, Alexander ER, et al. Simplified microimmunofluorescence test with trachoma lymphogranuloma venereum (Chlamydia trachomatis) antigen for use as a screening test for antibody. Journal of Clinical Microbiology. 1975;1:250–255
  12. Paukku M, Närvänen A, Puolakkainen M, et al. Detection of Chlamydia trachomatis antibodies by 2 novel tests: rELISA and peptide EIA. International Journal of STD & AIDS. 1998;10:604–607
  13. Keat A. Reiter's syndrome and reactive arthritis in perspective. The New England Journal of Medicine. 1983;309:1606–1615
  14. Leirisalo-Repo M, Hannu T, Mattila L. Microbial factors in spondyloarthropathies: insights from population studies. Current Opinion in Rheumatology. 2003;15:408–412
  15. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatism Scandinavia. 1969;15:232–253
  16. Dumonde DC. Introduction to part II. Principal evidence associating rheumatic diseases with microbial infection. In:  Dumonde DC editors. Infection and Immunology in the Rheumatic Diseases. Oxford: Blackwell; 1976;p. 95–96
  17. Keat AC, Thomas B, Dixey J, et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987;i:72–74
  18. Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. The New England Journal of Medicine. 1989;320:216–221
  19. Granfors K, Jalkanen S, Lindberg AA, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990;335:685–688
  20. Gaston JSH, Lillicrap MS. Arthritis associated with enteric infection. Best Practice & Research. Clinical Rheumatology. 2003;27:219–239
  21. Inman RD, Whittum-Hudson JA, Schumacher HR, et al. Chlamydia and associated arthritis. Current Opinion in Rheumatology. 2000;12:254–262
  22. Braun J, Kigsley G, van der Heijde D, et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, 3–6 July 1999. The Journal of Rheumatology. 2000;27:2185–2192
  23. Amor B. Reiter's syndrome. Diagnosis and clinical features. Rheumatic Diseases Clinics of North America. 1998;24:677–695
  24. Calin A. Terminology, introduction, diagnostic criteria, and overview. In:  Calin A,  Taurog JD editor. The Spondylarthritides. Oxford: Oxford University Press; 1998;p. 1–15
  25. Leirisalo M, Skylv G, Kousa M, et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis and Rheumatism. 1982;25:249–259
  26. Tertti R, Granfors K, Lehtonen O-P. An outbreak of Yersinia pseudotuberculosis infection. The Journal of Infectious Diseases. 1984;149:245–250
  27. Hannu T, Mattila L, Nuorti JP, et al. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O: 3 infection. Annals of the Rheumatic Diseases. 2003;62:866–869
  28. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. Western Journal of Medicine. 1994;161:148–152
  29. Paronen I. Reiter's disease. A study of 344 cases observed in Finland. Acta Medica Scandinavica. 1948;131(supplement 212):1–113
  30. Granfors K. Do bacterial antigens cause reactive arthritis?. Rheumatic Diseases Clinics of North America. 1992;18:37–48
  31. Lauhio A, Lähdevirta J, Janes R, et al. Reactive arthritis associated with Shigella sonnei infection. Arthritis and Rheumatism. 1988;31:1190–1193
  32. Mazumder RN, Salam MA, Ali MA, et al. Reactive arthritis associated with Shigella dysenteriae type I infection. Journal of Diarrhoeal Diseases Research. 1997;15:21–24
  33. Goudswaard J, Sabbe L, te Winkel W. Reactive arthritis as a complication of Campylobacter lari enteritis. The Journal of Infection. 1995;31:171–176
  34. Cooper SM, Ferris JA. Reactive arthritis and psittacosis. The American Journal of Medicine. 1986;81:555–557
  35. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae—a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Annals of the Rheumatic Diseases. 1994;53:100–105
  36. Hannu T, Puolakkainen M, Leirisalo-Repo M. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology. 1999;38:411–414
  37. Putterman C, Rubinow A. Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Seminars in Arthritis and Rheumatism. 1993;22:420–426
  38. Valtonen VV, Leirisalo M, Pentikäinen PJ, et al. Triggering infections in reactive arthritis. Annals of the Rheumatic Diseases. 1985;44:399–405
  39. Ahmed S, Ayoub EM, Scornik JC, et al. Poststreptococcal reactive arthritis. Clinical characteristics and association with HLA-DR alleles. Arthritis and Rheumatism. 1998;41:1096–1102
  40. Jansen TLTA, Janssen M, van Riel PLCM. Acute rheumatic fever or post-streptococcal reactive arthritis: a clinical problem revisited. British Journal of Rheumatology. 1998;37:335–340
  41. Rosenthal L, Olhagen B, Ek S. Aseptic arthritis after gonorrhoea. Annals of the Rheumatic Diseases. 1980;39:141–146
  42. Toivanen P, Toivanen A. Two forms of reactive arthritis?. Annals of the Rheumatic Diseases. 1999;58:737–741
  43. Erlacher L, Wintersberger W, Menschnik M, et al. Reactive arthritis: urogenital swab culture in the only useful diagnostic method for the detection of the arthritogenic infection in extra-articularly asymptomatic patients with undifferentiated oligoarthritis. British Journal of Rheumatology. 1995;34:838–842
  44. Horner P, Thomas B, Gilroy CB, et al. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clinical Infectious Diseases. 2001;32:995–1003
  45. Schaeverbeke T, Vernhes JP, Lequen L, et al. Mycoplasmas and arthritides. Review Rhumatologie English Edition. 1997;64:120–128
  46. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis and Rheumatism. 1991;34:1218–1230
  47. Willkens RF, Arnett FC, Bitter T, et al. Reiter's syndrome, Evaluation of preliminary criteria for definite disease. Arthritis and Rheumatism. 1981;24:844–849
  48. Pacheco-Tena C, Burgos-Vargas R, Vázquez-Mellado J, et al. A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. The Journal of Rheumatology. 1999;26:1338–1346
  49. Kingsley G, Sieper J. Third International Workshop on reactive arthritis. Annals of the Rheumatic Diseases. 1996;55:564–570
  50. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of veneral disease and Reiter's syndrome in a Greenland population. Arthritis and Rheumatism. 1992;35:190–194
  51. Locht H, Kihlström E, Lindström FD. Reactive arthritis after salmonella among medical doctors—study of an outbreak. The Journal of Rheumatology. 1993;20:845–848
  52. Mattila L, Leirisalo-Repo M, Pelkonen P, et al. Reactive arthritis following an outbreak of Salmonella bovismorbificans infection. The Journal of Infection. 1998;36:289–295
  53. Hannu T, Mattila L, Siitonen S, Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Annals of the Rheumatic Diseases. 2002;61:264–266
  54. Locht H, Krogfelt KA. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli. Annals of the Rheumatic Diseases. 2002;61:448–452
  55. Hoogkamp-Korstanje JAA, de Koning J, Heeseemann J, et al. Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with yersinia-associated spondylarthropathy. Infection. 1992;20:53–57
  56. Lauhio A, Leirisalo-Repo M, Lähdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis. Arthritis and Rheumatism. 1991;34:23–35
  57. Wollenhaupt J, Hammer M, Pott HG, et al. double-blind placebo-controlled comparison of 2 weeks versus 4 months treatmen with doxycycline in chlamydia-induced arthritis. Arthritis and Rheumatism. 1997;40:S143
  58. Hoogkamp-Korstanje JA, Moesker H, Bruyn GA. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Annals of the Rheumatic Diseases. 2000;59:914–917
  59. Kvien TK, Gaston JS, Bardin T, et al. Three months treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Annals of the Rheumatic Diseases. 2004;63:1113–1119
  60. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in subjects with reactive arthritis and undifferentiated oligoarthritis. A three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheumatism. 1999;42:1386–1396
  61. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Annals of the Rheumatic Diseases. 2000;59:565–570
  62. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Annals of the Rheumatic Diseases. 2003;62:880–884
  63. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic therapy and long-term prognosis of reactive arthritis. Annals of the Rheumatic Diseases. 2003;62:655–658
  64. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheumatic Diseases Clinics of North America. 1998;24:737–751
  65. Sairanen E, Paronen I, Mähönen H. Reiter's syndrome: a follow-up study. Acta Medica Scandinavica. 1969;185:57–63
  66. Leirisalo-Repo M, Suoranta H. Ten-year followup study of patients with yersinia arthritis. Arthritis Rheumatism. 1988;31:533–537
  67. Berglöf F-E. Arthritis and intestinal infection. Acta Rheumatism Scandinavia. 1963;9:141–149
  68. Stein HB, Abdullah A, Robinson HS, et al. Salmonella reactive arthritis in British Columbia. Arthritis Rheumatism. 1980;23:206–210
  69. Short CD, Klouda PT, Smith L. Campylobacter jejuni enteritis and reactive arthritis. Annals of the Rheumatic Diseases. 1982;41:287–288
  70. Thomson GT, DeRubeis DA, Hodge MA, et al. Post-salmonella reactive arthritis: late clinical sequelae in a point source cohort. American Journal of Medicine. 1995;98:13–21
  71. Leirisalo-Repo M, Helenius P, Hannu T, et al. Long-term prognosis of reactive salmonella arthritis. Annals of the Rheumatic Diseases. 1997;56:516–520
  72. Herrlinger JD, Asmussen J-U. Long term prognosis in yersinia arthritis: clinical and serological findings. Annals of the Rheumatic Diseases. 1992;51:1332–1334
  73. Amor B. Reiter's syndrome: a long-term follow-up data. Annals of the Rheumatic Diseases. 1979;38(supplment 1):32–33
  74. Lehtinen A, Taavitsainen M, Leirisalo-Repo M. Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clinical and Experimental Rheumatology. 1994;12:143–148
  75. Bremell T, Bjelle A, Svedhem å. Rheumatic symptoms following an outbreak of campylobacter enteritis: a five year follow up. Annals of the Rheumatic Diseases. 1991;50:934–938
  76. Fox R, Calin A, Gerber RC, et al. The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Annals of Internal Medicine. 1979;91:190–193
  77. Hoogkamp-Korstanje JAA. Antibiotics in Yersinia enterocolitica infections. Journal of Antimicrobial Chemotherapy. 1987;20:123–131
  78. Hoogkamp-Korstanje JAA, de Koning J, Heeseemann J. Persistence of Yersinia enterocolitica in man. Infection. 1988;16:81–88
  79. Bas S, Griffais R, Kvien T, et al. Amplification of plasmid and chromosome chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthritis. Arthritis Rheumatism. 1995;38:1005–1013
  80. Dequeker J, Jamar R, Walravens M. HLA-B27, arthritis and Yersinia enterocolitica infection. Journal of Rheumatology. 1980;7:706–710
  81. Glennås A, Kvien TK, Melby K, et al. Reactive arthritis: a favourable 2 year course and outcome, independent of triggering agent and HLA-B27. Journal of Rheumatology. 1994;21:2274–2280
  82. Mielants H, Veys EM, Goemaere S, et al. Gut inflammation in the spondylarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. Journal of Rheumatology. 1991;18:1542–1551
  83. Olhagen B. Postinfective or reactive arthritis. Scandinavian Journal of Rheumatology. 1980;9:193–202
  84. Calin A. Reiters's syndrome. In:  Calin A editors. Spondylarthropathies. Orlando: Grune & Stratton; 1984;p. 119–150
  85. Kalliomäki JL, Leino R. Follow-up study of joint complications in yersinosis. Acta Medica Scandinavica. 1979;205:521–525
  86. Marsal L, Winblad S, Wollheim FA. Yersinia enterocolitica arthritis in southern Sweden: a four-year follow-up study. British Medical Journal. 1981;283:101–103
  87. Yli-Kerttula T, Tertti R, Toivanen A. Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak. Clinical and Experimental Rheumatology. 1995;13:333–337

PII: S1521-6942(06)00030-1

doi: 10.1016/j.berh.2006.02.003

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 419-433 , June 2006

Article Tools